Pipeline

CLN-2588

Actomyolytic for Essential Tremor, Childhood Epilepsies and Stiff Person Syndrome

CLN-2501

Smooth muscle relaxant for capillary reflow after ischemia

CLX-001

Myosin-10 inhibitor to stop metastasis and tumor growth

First-in-class anti-spastic drug candidate for muscle spasticity and myotonia to treat 15 million patients

MTR-601 is now in

Phase 2a

Phase 1 clinical trial details are on ClinicalTrials.gov:

Phase 2a clinical trial details are on ClinicalTrials.gov:

Page updated

Google Sites

Report abuse